{"doi":"10.1037/ccp0000928","title":"Mediators of a randomized controlled trial of a preventive intervention for youth of parents with depressive disorders.","abstract":"OBJECTIVE: The present study assessed two theory-driven mediators of the effects of a family group cognitive-behavioral (FGCB) preventive intervention for youth of parents with a history of major depressive disorder (MDD) or dysthymia on long-term youth psychopathology symptoms and diagnoses. METHOD: = 11.4, 49% female, 74% White, non-Hispanic). Changes in the hypothesized mediators, observations of positive parenting (Iowa Family Interaction Rating Scales) and youth secondary control coping (SCC) skills (Responses to Stress Questionnaire), were assessed at 6 months. Changes in youth psychopathology symptoms were assessed on the Child Behavior Checklist and Youth Self-Report at 18- and 24-month follow-ups and MDD diagnoses with the Kiddie Schedule for Affective Disorders and Schizophrenia at 12 and 24 months. RESULTS: Changes in youth SCC skills (e.g., acceptance, reappraisal) after the intervention mediated the effects of the FGCB program on changes in youth internalizing and externalizing symptoms at 18- and 24-month follow-ups. Effects for changes in positive parenting behaviors as a mediator were more limited. SCC skills were further shown to mediate the effects of the FGCB intervention on MDD diagnoses from 12 to 24 months. CONCLUSIONS: This study provides clear and strong evidence that changes in youth SCC skills mediated the long-term effects of preventive intervention for families of depressed parents. (PsycInfo Database Record (c) 2025 APA, all rights reserved).","journal":"Journal of Consulting and Clinical Psychology","year":2025,"id":538445,"datarank":0.23771626166623236,"base_score":1.3862943611198906,"endowment":1.3862943611198906,"self_citation_contribution":0.20794415416798362,"citation_network_contribution":0.029772107498248733,"self_endowment_contribution":0.20794415416798362,"citer_contribution":0.029772107498248733,"corpus_percentile":null,"corpus_rank":null,"citation_count":3,"citer_count":3,"citers_with_citation_signal":2,"citers_with_endowment":2,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9187,"is_data_producer":true,"deposit_databanks":{"ClinicalTrials.gov":["NCT00183482"]},"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":425875,"name":"Abigail Pine","orcid":"0000-0001-6970-5808","position":1,"is_corresponding":false},{"id":599826,"name":"David A. Cole","orcid":"0000-0002-7535-1230","position":2,"is_corresponding":false},{"id":597251,"name":"Laura G. McKee","orcid":"0000-0002-1660-1754","position":3,"is_corresponding":false},{"id":597255,"name":"Rex Forehand","orcid":"0000-0002-5954-4032","position":4,"is_corresponding":false},{"id":599825,"name":"Bruce E. Compas","orcid":"0000-0002-5884-181X","position":5,"is_corresponding":false},{"id":945311,"name":"Abagail E. Ciriegio","orcid":"0000-0002-8018-8562","position":0,"is_corresponding":true}],"reference_count":0,"raw_metadata":null,"created_at":"2026-07-19T02:52:21.389196Z","pmid":"39786802","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}